Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) (IRB 262319)


Collapse Overview 
Collapse sponsor award id
SAV006-05


Collapse Biography 

Collapse Time 
Collapse start date
2021-07-27

Collapse end date
2031-07-26